Aligned Genetics

Aligned Genetics EBIT per Share

The EBIT per Share of Aligned Genetics (238120.KQ) as of Oct 30, 2026 is 339.80 KRW. In the previous year, EBIT per Share was 386.62 KRW — a change of -12.11% (lower).

EBIT per Share

339.80KRW

YoY

-12.11%

Last updated:

EBIT per Share of Aligned Genetics is 2025 339.80 KRW. EBIT per Share of Aligned Genetics was 2024 386.62 KRW. It decreases by -12.11% lower compared to the previous year.

The Aligned Genetics EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-267.60 KRW
Jan 1, 2019
-55.49 KRW
Jan 1, 2020
-35.26 KRW
Jan 1, 2021
303.08 KRW
Jan 1, 2022
396.28 KRW
Jan 1, 2023
483.77 KRW
Jan 1, 2024
386.62 KRW
Jan 1, 2025
339.80 KRW
The Aligned Genetics EBIT per Share history
YEAREBIT per ShareYoY
339.80KRW-12.11%
386.62KRW-20.08%
483.77KRW+22.08%
396.28KRW+30.75%
303.08KRW-959.62%
-35.26KRW-36.46%
-55.49KRW-79.26%
-267.60KRW+4.12%
-257.01KRW+10.44%
-232.71KRW+347.90%
-51.96KRW-70.24%
-174.55KRW+21.50%
-143.67KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Aligned Genetics Stock analysis

What does Aligned Genetics do? Aligned Genetics Inc, based in Anyang, South Korea, operates in the Health Care sector within the Life Sciences Tools & Services industry. The company commercializes innovative products for life science research, including automated cell counters like LUNA and LUNA-FL, tissue clearing systems such as X-CLARITY, and digital cell imaging systems like iRiS. Listed on November 3, 2016, it serves the global research community with advanced laboratory solutions. Aligned Genetics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aligned Genetics stock

EBIT per Share of Aligned Genetics is 339.80 KRW in 2025.

EBIT per Share of Aligned Genetics changed from 386.62 KRW to 339.80 KRW, representing a -12.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Aligned Genetics since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Aligned Genetics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Aligned Genetics